Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

Clinical trial NCT06822790 · RECRUITING

Trial details

NCT number: NCT06822790
Sponsor: Arrowhead Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hypertriglyceridemia

Start date: 2025-04-09
Primary completion: 2028-07-01
Enrollment: 869

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.